As 2025 unfolds, the next competitive advantage in precision medicine may no longer lie in discovery but in real-world validation. While genomics, AI, and advanced therapies have transformed the way diseases are targeted, Real-world Evidence (RWE) is reshaping how those breakthroughs earn market traction, reimbursement, and clinical adoption.
Welcome to Visiongain Market Watch. Here you’ll find unbiased reporting, market briefings and real-time industry commentary. Our incisive editorial voice draws on decades of expertise, interviews with market leaders and meticulous analysis to bring you news, articles and press stories that matter.
Click on the tabs below to find the latest industry updates and global market forecasts.


















